What vaccines are available for epidemic hemorrhagic fever

There are mainly two kinds of vaccines for preventing epidemic hemorrhagic fever, namely, inactivated bivalent hemorrhagic fever with renal syndrome vaccine and purified bivalent hemorrhagic fever with renal syndrome vaccine. The vaccination objects are all high risk people aged 16-60 in epidemic areas. The inactivated bivalent hemorrhagic fever with renal syndrome vaccine needs to be vaccinated with 3 doses, and the purified bivalent hemorrhagic fever with renal syndrome vaccine needs to be vaccinated with 2 doses. The positive conversion rate of neutralizing antibody in the first year after basic immunization is 94.7%, and the third year is 98.0%. At

present, there are two kinds of vaccines that can be used to prevent epidemic hemorrhagic fever, namely inactivated vaccine of bivalent hemorrhagic fever with renal syndrome and purified vaccine of bivalent hemorrhagic fever with renal syndrome.

target of inactivated bivalent HFRS vaccine was high risk population aged 16-60 in epidemic area. Generally, 3 doses were given with 7 days interval between the first two doses and 1 year interval between the third dose. The positive conversion rate of neutralizing antibody was 94.7% in the first year after basic immunization and 98.0% in the third year.

Bivalent HFRS purified vaccine targets high-risk groups aged 16-60 in epidemic areas. Generally, two doses are given at an interval of 14 days. The neutralizing antibody positive conversion rate is 94.7% in the first year after basic immunization and 98.0% in the third year.

should be noted that the following groups are prohibited from vaccination

Known allergies to any of the components of the vaccine, including excipients, formaldehyde, and antibiotics

Acute disease, severe chronic disease, acute episodes of chronic disease, and

Pregnant and lactating women.